Table 1 Characteristics of the T2D patients and non-T2D control participants.

From: Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 diabetes

Descriptive Variable

T2D (n = 24)

Non-T2D (n = 22)

p-value

Gender (M/F)

8/16

4/18

 

Age (years)

57.8 (10.9)

53.4 (10.7)

0.173

Body mass index (kg/m2)

32.1 (6.2)

30.1 (4.8)

0.233

Waist circumference (cm)

109.1 (19.4)

102.3 (13.5)

0.183

Fasting plasma glucose (mmol/L)

7.8 (0.8)*

5.8 (0.8)

<0.001

24 Hour CGM average glucose (mmol/L)

7.7 (1.8)*

5.8 (0.8)

0.003

Plasma TNF-α (pg/ml)

9.57 (5.98)*

5.75 (2.72)

0.009

Plasma IL6 (pg/ml)

3.02 (2.27)*

1.76 (0.94)

0.049

Plasma IL10 (pg/ml)

7.07 (5.93)

4.52 (3.99)

0.163

  1. T2D patients (n = 24) exhibit elevated fasting TNF-α (P = 0.009) and IL6 (P = 0.049) but no significant difference in fasting IL10 (P = 0.163) versus non-T2D control participants (n = 22). All values are mean (SD).
Back to article page